Final report of the PROTEMBO C Trial: a prospective evaluation of a novel cerebral protection device during TAVI
EuroIntervention
.
2024 Feb 19;20(4):e264-e267.
doi: 10.4244/EIJ-D-23-00743.
Authors
Simone Fezzi
1
,
Dariusz Jagielak
2
,
Radoslaw Targonski
2
,
Tobias Schmidt
3
,
Christian Frerker
3
,
Adam Ryszard Witkowski
4
,
Michael Lauterbach
5
,
Juergen Leick
5
,
Andrejs Erglis
6
,
Inga Narbute
6
,
Marek Grygier
7
,
Marcin Misterski
7
,
Derk Frank
8
,
Mohamed Abdel-Wahab
9
,
Johannes Wilde
9
,
Matti Adam
10
,
Fernando Gatto
11
,
Robert Zivadinov
12
,
Michael Dwyer
12
,
Nikos Werner
5
,
Darren Mylotte
1
Affiliations
1
Galway University Hospitals and University of Galway, Galway, Ireland.
2
Department of Cardiac & Vascular Surgery, Uniwersyteckie Centrum Kliniczne, Gdansk, Poland.
3
Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
4
National Institute of Cardiology, Warsaw, Poland.
5
Krankenhaus der Barmherzigen Brüder Trier, Trier, Germany.
6
Pauls Stradiņš Clinical University Hospital, University of Latvia, Riga, Latvia.
7
1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
8
UKSH University Medical Center Schleswig-Holstein, Kiel, Germany and DZHK partner site Hamburg/Kiel/Lübeck, Germany.
9
Heart Center Leipzig, University of Leipzig, Leipzig, Germany.
10
Department of Internal Medicine III - Cardiology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
11
HerzZentrum Saar, Völklingen, Germany.
12
Buffalo Neuroimaging Analysis Center, University at Buffalo, Buffalo, NY, USA.
PMID:
38389472
PMCID:
PMC10870006
(available on
2025-02-19
)
DOI:
10.4244/EIJ-D-23-00743
No abstract available
MeSH terms
Aortic Valve Stenosis* / surgery
Brain / blood supply
Embolic Protection Devices*
Humans
Transcatheter Aortic Valve Replacement* / adverse effects